Literature DB >> 15243121

Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: case report.

M P Romero Gómez1, A M Peinado Esteban, J A Sobrino Daza, J A Sáez Nieto, D Alvarez, P Peña García.   

Abstract

We describe a case of infective endocarditis in a prosthetic mitral valve due to Ochrobactrum anthropi. Although O. anthropi is an emerging pathogen in immunocompromised patients, infections with the bacterium have very rarely been documented in healthy hosts, and endocarditis is rare. To our knowledge, only two cases of O. anthropi endocarditis have been reported in the medical literature.

Entities:  

Mesh：

Year:  2004        PMID： 15243121      PMCID： PMC446288          DOI： 10.1128/JCM.42.7.3371-3373.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Intravenous line infection due to Ochrobactrum anthropi (CDC Group Vd) in a normal host.

Authors:  M V Gill; H Ly; M Mueenuddin; P E Schoch; B A Cunha
Journal:  Heart Lung       Date:  1997 Jul-Aug       Impact factor: 2.210

Review 2.  Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related nonfermentative bacteria.

Authors:  T J Cieslak; M L Robb; C J Drabick; G W Fischer
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

3.  Bacteremia and urinary tract infection associated with CDC group Vd biovar 2.

Authors:  K G Van Horn; C A Gedris; T Ahmed; G P Wormser
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 4.  Infective endocarditis and septic embolization with Ochrobactrum anthropi: case report and review of literature.

Authors:  M S Mahmood; A R Sarwari; M A Khan; Z Sophie; E Khan; S Sami
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

5.  Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients.

Authors:  H J Chang; J C Christenson; A T Pavia; B D Bobrin; L A Bland; L A Carson; M J Arduino; P Verma; S M Aguero; K Carroll; E Jenkins; J A Daly; M L Woods; W R Jarvis
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

6.  Nomenclature for aerobic and facultative bacteria.

Authors:  D A Bruckner; P Colonna
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

7.  Bacteremia caused by Ochrobactrum anthropi in an immunocompromised child.

Authors:  M Haditsch; L Binder; G Tschurtschenthaler; R Watschinger; G Zauner; H Mittermayer
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

8.  Puncture wound osteochondritis of the foot caused by CDC group Vd.

Authors:  W J Barson; B A Cromer; M J Marcon
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

9.  Pancreatic abscess associated with Achromobacter group Vd biovar 1.

Authors:  P C Appelbaum; D B Campbell
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

10.  [Comparative susceptibility of Ochrobactrum anthropi, Agrobacterium tumefaciens, Alcaligenes faecalis, Alcaligenes denitrificans subsp. denitrificans, Alcaligenes denitrificans subsp. xylosidans and Bordetella bronchiseptica against 35 antibiotics including 17 beta-lactams].

Authors:  C Bizet; J Bizet
Journal:  Pathol Biol (Paris)       Date:  1995-04
View more
  9 in total

1.  Genome of Ochrobactrum anthropi ATCC 49188 T, a versatile opportunistic pathogen and symbiont of several eukaryotic hosts.

Authors:  Patrick S G Chain; Dorothy M Lang; Diego J Comerci; Stephanie A Malfatti; Lisa M Vergez; Maria Shin; Rodolfo A Ugalde; Emilio Garcia; Marcelo E Tolmasky
Journal:  J Bacteriol       Date:  2011-06-17       Impact factor: 3.490

Review 2.  Pelvic abscess due to Ochrobactrum intermedium [corrected] in an immunocompetent host: case report and review of the literature.

Authors:  Sagar A Vaidya; Diane M Citron; Marjorie B Fine; Georgette Murakami; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Clinical characteristics of Ochrobactrum anthropi bacteremia.

Authors:  Hideharu Hagiya; Kouhei Ohnishi; Miyako Maki; Naoto Watanabe; Tomoko Murase
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

4.  First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report.

Authors:  Magalie Menuet; Fadi Bittar; Nathalie Stremler; Jean-Christophe Dubus; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  J Med Case Rep       Date:  2008-12-05

5.  Prevalence, Host Range, and Comparative Genomic Analysis of Temperate Ochrobactrum Phages.

Authors:  Claudia Jäckel; Stefan Hertwig; Holger C Scholz; Karsten Nöckler; Jochen Reetz; Jens A Hammerl
Journal:  Front Microbiol       Date:  2017-06-30       Impact factor: 5.640

6.  Genomics of Ochrobactrum pseudogrignonense (newly named Brucella pseudogrignonensis) reveals a new bla OXA subgroup.

Authors:  Shu-Yuan Li; Yin-En Huang; Jhih-Yang Chen; Chung-Hsu Lai; Yan-Chiao Mao; Yao-Ting Huang; Po-Yu Liu
Journal:  Microb Genom       Date:  2021-08

7.  Ochrobactrum anthropi - An Emerging Opportunistic Pathogen in Musculoskeletal Disorders - A Case Report and Review of Literature.

Authors:  Madhan Jeyaraman; Sathish Muthu; Prasanna Sarangan; Naveen Jeyaraman; Rathinavelpandian Perunchezhian Packkyarathinam
Journal:  J Orthop Case Rep       Date:  2022-03

8.  Spontaneous bacterial peritonitis due to Ochrobactrum anthropi: a case report.

Authors:  Yu Mi Wi; Kyung-mok Sohn; Ji-young Rhee; Won Sup Oh; Kyong Ran Peck; Nam Young Lee; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

9.  A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi.

Authors:  Robert Leslie James Graham; Mohit K Sharma; Nigel G Ternan; D Brent Weatherly; Rick L Tarleton; Geoff McMullan
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.